Reemergence of JAK2 V617F clone heralds extramedullary leukemia relapse after BMT for transformed essential thrombocytosis.
Au
W Y
WY
Fung
A
A
Lie
A K
AK
Lam
K Y
KY
Lam
C C
CC
Kwong
Y L
YL
D016026:Bone Marrow Transplantation; D006086:Graft vs Host Disease; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics / Q000378:metabolism*; D007938:Leukemia / Q000201:enzymology* / Q000235:genetics / Q000473:pathology* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics; D010649:Phenylalanine / Q000235:genetics / Q000378:metabolism*; D012008:Recurrence; D013920:Thrombocythemia, Essential / Q000201:enzymology* / Q000235:genetics / Q000473:pathology / Q000601:surgery*; D017211:Treatment Failure; D014633:Valine / Q000235:genetics / Q000378:metabolism*
D010649:Phenylalanine; D053614:Janus Kinase 2; D014633:Valine